Fed. Circ. Bats Down Helsinn Bid To Stay On-Sale Bar Ruling

By Bonnie Eslinger (January 22, 2018, 10:53 PM EST) -- The Federal Circuit on Monday rejected Helsinn Healthcare's request to stay its ruling invalidating four patents related to an anti-nausea drug while the company seeks to put its case before the U.S. Supreme Court, saying the decision was narrowly tailored and Helsinn didn't show it faces irreparable injury....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!